Cargando…
Comparative onset of effect of biologics and small molecules in moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis
BACKGROUND: Onset of effect of advanced therapies is an important parameter due to symptom load and risk of disease complications in moderate-to-severe ulcerative colitis (UC), but comparative data are lacking. Therefore, we aimed to assess the comparative onset of efficacy of biological therapies a...
Autores principales: | Attauabi, Mohamed, Dahl, Emilie Kristine, Burisch, Johan, Gubatan, John, Nielsen, Ole Haagen, Seidelin, Jakob Benedict |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971510/ https://www.ncbi.nlm.nih.gov/pubmed/36864986 http://dx.doi.org/10.1016/j.eclinm.2023.101866 |
Ejemplares similares
-
Lipidomic Trajectories Characterize Delayed Mucosal Wound Healing in Quiescent Ulcerative Colitis and Identify Potential Novel Therapeutic Targets
por: Bjerrum, Jacob Tveiten, et al.
Publicado: (2022) -
COX-2–PGE(2) Signaling Impairs Intestinal Epithelial Regeneration and Associates with TNF Inhibitor Responsiveness in Ulcerative Colitis
por: Li, Yuan, et al.
Publicado: (2018) -
Putative biomarkers of vedolizumab resistance and underlying inflammatory pathways involved in IBD
por: Soendergaard, Christoffer, et al.
Publicado: (2018) -
Evidence for Impaired CARD15 Signalling in Crohn's Disease without Disease Linked Variants
por: Seidelin, Jakob Benedict, et al.
Publicado: (2009) -
pcaGoPromoter - An R Package for Biological and Regulatory Interpretation of Principal Components in Genome-Wide Gene Expression Data
por: Hansen, Morten, et al.
Publicado: (2012)